Frontiers in Oncology | Molecular and Cellular Oncology

Case Report

Published on 14 Aug 2025

Mucinous adenocarcinoma of the prostate with extremely low prostate-specific antigen levels, recurrent disease: a case report

in Molecular and Cellular Oncology

Xu Yu
Jie Yuan
Zhiming Wang
Niannian Wang
Xiangfei He
Jie Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1645306

128 views

Mini Review

Published on 13 Aug 2025

Molecular mechanism of aerobic exercise in miRNAs and the anti-tumoral effects

in Molecular and Cellular Oncology

Merve Çulha
Fabio S. Lira
Jose C. Rosa-Neto

Frontiers in Oncology

doi 10.3389/fonc.2025.1595982

203 views

Review

Published on 13 Aug 2025

Application of artificial intelligence-based stemness index in cancer

in Molecular and Cellular Oncology

Liyuan Liu
Qin Pei
Javeria Qadir
Yiyu Chen
Jingyuan Li
Yanan Luo
Jiawen Xian
Rongrong Du
Ting Ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1608712

311 views

Original Research

Accepted on 12 Aug 2025

Identification of MAEA protein as a potential target for chemoresistance in osteosarcoma using bioinformatics and proteomic analysis

in Molecular and Cellular Oncology

Chen Zhang
Ruizhen Wang
Xin Yi
Wannian Wang
Jing Yang
Lihua Zhang
Guibin Wang
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1597750

Original Research

Accepted on 12 Aug 2025

Histologic Grade and STAS As Key Predictors Of Distant Recurrence In Resected Early-Stage Lung Adenocarcinoma: A Single-Center Study

in Molecular and Cellular Oncology

Alessandro Bonis
Giulia Pagliarini
Giovanni Comacchio
Marco Mammana
Federica Pezzuto
Vincenzo Verzeletti
Enrica Pellizzer
Alessandro Berni
Stefano Silvestrin
Giorgio Cannone

Frontiers in Oncology

doi 10.3389/fonc.2025.1626863

Original Research

Accepted on 11 Aug 2025

REST corepressor 2 contributes to the cell proliferation of endometrial cancer

in Molecular and Cellular Oncology

Qingjuan Zhu
Xin Yang
Yuchun Lu

Frontiers in Oncology

doi 10.3389/fonc.2025.1539263

106 views

Original Research

Published on 11 Aug 2025

Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91

in Molecular and Cellular Oncology

Lei Song
Jing Han
Run Wang
Shen Cao
Yi Tai
Xinyu Wang
Yanjin Zheng
Shufeng Jin
Yiqian Shen
Cai Qin Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1607264

405 views

Systematic Review

Published on 11 Aug 2025

A systematic review and exploration of clinical application of liver depression syndrome in breast cancer

in Molecular and Cellular Oncology

Peng Wu
Siying Mao
Qian Zuo
Qianqian Guo
Qianjun Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1614903

302 views

Original Research

Accepted on 07 Aug 2025

Construction of a Glycosylation-related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Soft Tissue Sarcoma

in Molecular and Cellular Oncology

Ningning Yuan
Jinfeng Zhang
Junhui Yuan
Zhou Xie
Yuanjun Gao
Muqaddas Raza
Yutong Gao
Guowei Zuo

Frontiers in Oncology

doi 10.3389/fonc.2025.1636830

Correction

Accepted on 07 Aug 2025

Correction: "Neutrophil Extracellular Traps and Cannabinoids: Potential in Cancer Metastasis"

in Molecular and Cellular Oncology

Izabela Krauze
Beata Greb-Markiewicz
Anna Kłopot
Kamila Maciejewska
Michał Bryk
Małgorzata Krzystek-Korpacka

Frontiers in Oncology

doi 10.3389/fonc.2025.1663602

Review

Accepted on 06 Aug 2025

The Paradoxical Role of Stem Cells in Osteosarcoma: From Pathogenesis to Therapeutic Breakthroughs

in Molecular and Cellular Oncology

Zhengbing Su
Xiang Fang
Hong Duan

Frontiers in Oncology

doi 10.3389/fonc.2025.1643491

244 views

Original Research

Published on 05 Aug 2025

Chorordin-like 1 inhibits pancreatic cancer cell migration and invasion: involvement of the BMP4/SMAD pathway

in Molecular and Cellular Oncology

Wei Li
Yalan Zhong
Yuqiao Song
Hongmei Wang
Zheng Jiang

Frontiers in Oncology

doi 10.3389/fonc.2025.1633464

471 views

Review

Accepted on 04 Aug 2025

High risk factors, molecular features and clinical management for radioactive iodine-refractory differentiated thyroid carcinoma

in Molecular and Cellular Oncology

Tengyun Ma
Yiting Xie
Xinyi Long
Feng Ye

Frontiers in Oncology

doi 10.3389/fonc.2025.1644562

274 views

Original Research

Accepted on 31 Jul 2025

NEK4 SUPPRESSES CELL PROLIFERATION IN BT20 TRIPLE NEGATIVE BREAST CANCER CELLS BY DIMINISHING EXPRESSION OF CELL CYCLE GENES WHILE ITS DEPLETION MITIGATES PROLIFERATION IN OTHER CELL LINES

in Molecular and Cellular Oncology

RASHMI R JOSHI
E GLORIA SEPULVEDA
F ESTER LUJAN
JACOB DEVARGAS
AMANDA K ASHLEY

Frontiers in Oncology

doi 10.3389/fonc.2025.1547899

146 views

Review

Published on 31 Jul 2025

Advances in research on RNA methylation and cancer radiotherapy resistance

in Molecular and Cellular Oncology

Hui Liu
Hui Luo
Ming Jin
Zhen Zheng
Yang Xi
Kaitai Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1596541

593 views

Original Research

Accepted on 30 Jul 2025

EPHA2 Promotes Triple-Negative Breast Cancer Progression by Suppressing Pyroptosis via the AKT/PI3K/mTOR Pathway

in Molecular and Cellular Oncology

Xiaoying Huang
Na Li
Qingkai Han
Qilun Liu
Li-gang Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1620122

143 views